Hematology TimesFDA grants priority review for drug to treat APLSeptember 14, 2017Leukemia, Myelodysplasia, TransplantationPharmacy
Oncology PracticeSurgeons strongly influenced chances of contralateral prophylactic mastectomySeptember 13, 2017Breast Cancer
Oncology PracticeUninsured rate falls to record low of 8.8%September 13, 2017Practice ManagementBusiness of Medicine
Hematology NewsKW-2478 examined as novel add-on therapy for myelomaSeptember 13, 2017Multiple MyelomaLymphoma & Plasma Cell Disorders
Oncology PracticePatient and physician outreach boost CRC screening ratesSeptember 13, 2017Preventive Care
Hematology TimesR&D costs for cancer drugs may be lower than previously thoughtSeptember 13, 2017PharmacyRelated Issues
Hematology NewsBiosimilar matches rituximab in large follicular lymphoma trialSeptember 12, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
Oncology PracticeAnalysis: Actual cancer drug R&D costs are far less than widely publicized sumSeptember 12, 2017Practice ManagementLung CancerBusiness of MedicineGI Oncology
Oncology PracticeTen-year outcomes support skipping axillary lymph node dissection with positive sentinel nodesSeptember 12, 2017Breast Cancer
Oncology PracticeCOMBI-AD: Adjuvant combo halves relapses in BRAF V600-mutated melanomaSeptember 12, 2017Melanoma
Hematology TimesBiosimilar deemed equivalent to reference drug in FLSeptember 12, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesTreatment for WDTC tied to increased risk of AMLSeptember 12, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesSynthetic heparin poised for clinical trials, team saysSeptember 12, 2017AnemiaThrombosis
